These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9196222)
21. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units. Gill CJ; Ponticas S; Shungu DL; Guerriero S Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid. Fuchs PC; Barry AL; Jones RN J Clin Microbiol; 1988 Jun; 26(6):1246-7. PubMed ID: 3384939 [TBL] [Abstract][Full Text] [Related]
24. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin]. Acar N; Diri MC; Türkyilmaz FR Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705 [TBL] [Abstract][Full Text] [Related]
25. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729 [TBL] [Abstract][Full Text] [Related]
26. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Pankuch GA; Jacobs MR; Appelbaum PC J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200 [TBL] [Abstract][Full Text] [Related]
27. [Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations]. Cokça F; Altay G Mikrobiyol Bul; 1992 Oct; 26(4):333-7. PubMed ID: 1435363 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics. Perryman F; Johnson S; Qadri SM Chemotherapy; 1983; 29(2):111-5. PubMed ID: 6839863 [TBL] [Abstract][Full Text] [Related]
29. Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors. Carsenti-Etesse H; Durant J; De Salvador F; Bensoussan M; Bensoussan F; Pradier C; Bernard E; Mondain V; Thabaut A; Dellamonica P Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1058-62. PubMed ID: 7889969 [TBL] [Abstract][Full Text] [Related]
30. Escherichia coli resistant to ampicillin/sulbactam. Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections. Naber KG; Wittenberger R Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011 [TBL] [Abstract][Full Text] [Related]
32. Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates. O'Halloran C; Walsh N; O'Grady MC; Barry L; Hooton C; Corcoran GD; Lucey B Br J Biomed Sci; 2018 Jan; 75(1):24-29. PubMed ID: 29210602 [TBL] [Abstract][Full Text] [Related]
33. Study of the in vitro activity of amoxicillin/clavulanic acid and other beta-lactam antibiotics against Escherichia coli isolated from urine specimens. Vanhoof R; Carpentier M; Delannoy P; Fagnart O; Lontie M; Mans I; Nyssen HJ; Van Nimmen L Acta Clin Belg; 2001; 56(1):32-7. PubMed ID: 11307481 [TBL] [Abstract][Full Text] [Related]
34. Comparison of amoxicillin and ampicillin activities in a continuous culture model of the human urinary bladder. Anderson JD; Johnson KR; Aird MY Antimicrob Agents Chemother; 1980 Apr; 17(4):554-7. PubMed ID: 6994635 [TBL] [Abstract][Full Text] [Related]
35. [Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor]. Casellas JM; Visser M; Tomé G; Cohen H; Soutric J; Arenoso H Enferm Infecc Microbiol Clin; 2001 May; 19(5):206-10. PubMed ID: 11446908 [TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits. Fuchs PC; Barry AL; Thornsberry C; Gavan TL; Jones RN Antimicrob Agents Chemother; 1983 Jul; 24(1):31-8. PubMed ID: 6625554 [TBL] [Abstract][Full Text] [Related]
37. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae. Siu LK; Cheng WL; Ho PL; Ng WS; Chau PY; Lo JY APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419 [TBL] [Abstract][Full Text] [Related]
38. Failure to correlate ampicillin and amoxicillin resistance by standard disk susceptibility tests and minimal inhibitory concentration in Haemophilus species. Pellegrino MB; Stefani S; Russo G Microbiologica; 1989 Jul; 12(3):267-71. PubMed ID: 2789330 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species. Barry AL; Hoeprich PD Antimicrob Agents Chemother; 1973 Sep; 4(3):354-60. PubMed ID: 4202343 [TBL] [Abstract][Full Text] [Related]
40. Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response. Jones RN; Dudley MN Diagn Microbiol Infect Dis; 1997 May; 28(1):5-18. PubMed ID: 9218913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]